Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

Share Price is delayed by 15 minutes
Get Live Data
15.95    0.00 (0.00%)
Bid:
15.00
Ask:
16.90
Spread: 1.90 (12.667%)
Market Cap: £12.88m
LMS Live PriceLast checked at - London Stock Exchange

Intraday Lms Capital Share Chart

Exercise of Warrants

1 Jun 2018 07:00

RNS Number : 9199P
LMS Capital PLC
01 June 2018
 

1 June 2018

LMS Capital plc ("LMS" or "the Company")

Exercise of warrants to acquire shares in Gresham House PLC ("Gresham")

The Company has exercised its 909,908 warrants to acquire shares in Gresham. The warrants had an exercise date of no later than 30 June 2018, and an exercise price of 323.27p per Gresham share.

The company has retained 182,344 of the shares acquired on exercising the warrants and has sold 727,564 shares at a price of 420p per share.

In determining the number of shares to be retained or sold, the Company sought to hold a 5% interest in the share capital based on shares in issue by Gresham immediately following its recent acquisition. Gresham has further warrants outstanding which will dilute the Company's holding as and when exercised.

The shares retained from the warrant exercise, together with the shares in Gresham it already held, brings the Company's holding in Gresham to 984,329 shares (4.97% of the current issued share capital).

Background

As part of the arrangements in August 2016, whereby Gresham House Asset Management was appointed to manage the Company's portfolio, the Company agreed that, to increase alignment between the Company and the manager, it would invest up to £1.5 million to acquire shares and warrants in Gresham in order to allow the Company's shareholders to benefit from any accretion in value to Gresham.

The Company fulfilled its £1.5 million investment target through the acquisition of shares in the market and the purchase of 909,908 warrants issued by Gresham. The warrants were issued at a price of 28p each, had an exercise date of no later than 30 June 2018, and an exercise price of 323.27p per share. All the warrants have been exercised.

Impact on cash and net asset value at 31 March 2018

The exercise cost of the 909,908 warrants was £2.94 million. Net proceeds from the sale of 727,564 shares was £3.05 million.

At 31 March 2018, the Gresham shares then held by the Company and the unexercised warrants were valued at £4 million based on a Gresham share price of 408p per share at that date.

Following the warrant exercise and retention of 182,344 of the shares acquired, the Company holds 984,289 Gresham shares the value of which, based on Gresham's closing share price of 443p per share on 31 May 2018, is £4.36 million. This is an increase of £0.36 million on the 31 March 2018 value. In addition, net cash increased by £0.11 million as a result of the proceeds from the 727,564 shares sold, more than offsetting the cost of exercising all the warrants and retaining shares to increase the Gresham holding.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

For further information please contact:  

LMS Capital PLC 020 3837 6275

Martin Knight, Chairman

 

Gresham House Asset Management

Graham Bird, Investment Director 020 3837 6275

 

J.P. Morgan Cazenove

Michael Wentworth-Stanley 0207 742 4000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBLGDURBXBGIB
Date   Source Headline
13th May 20263:32 pmRNSResults of 2026 Annual General Meeting
24th Apr 20263:37 pmRNSTR‑1: Notification of Major Holdings
24th Apr 20267:00 amRNSFirst Quarter 2026 Update
17th Apr 20261:09 pmRNSNotice of Annual General Meeting
19th Mar 20267:00 amRNSFinal Results for the Year Ended 31 December 2025
17th Feb 202612:37 pmRNSTR‑1: Notification of Major Holdings
16th Feb 20267:00 amRNSCompany Update and Unaudited Net Asset Value
13th Jan 20267:00 amRNSSecond Return of Capital
4th Nov 20257:00 amRNS3rd Quarter Trading Update
8th Oct 20259:30 amRNSChange of Auditor
11th Aug 20257:01 amRNSHalf-year Report
11th Aug 20257:00 amRNSInvestment in Dacian
15th Jul 20253:21 pmRNSTotal Voting Rights
8th Jul 20257:00 amRNSStatement re B Share issue
15th May 202510:23 amRNSResult of AGM & GM
14th May 20253:01 pmRNSResult of AGM & GM
14th May 20257:00 amRNSAGM Statement
24th Apr 202510:43 amRNSNotice of GM Broadcast
24th Apr 202510:36 amRNSNotice of GM
22nd Apr 20257:00 amRNS1st Quarter Results
8th Apr 20251:47 pmRNSNotice of AGM Broadcast
8th Apr 20251:34 pmRNSNotice of AGM
28th Mar 20257:00 amRNSFinal Results
17th Mar 20259:07 amRNSHolding(s) in Company
13th Mar 20257:00 amRNSStatement re proposed managed realisation
25th Feb 20251:27 pmRNSHolding(s) in Company
19th Feb 20258:44 amRNSHolding(s) in Company
13th Feb 20257:00 amRNSNet Asset Value(s)
20th Dec 20249:22 amRNSDirector/PDMR Shareholding
13th Nov 20244:32 pmRNSCompany Secretary Change
18th Oct 20247:00 amRNSThird Quarter 2024 Update
5th Sep 20243:49 pmRNSDirector/PDMR Shareholding
31st Jul 20247:00 amRNSSenior Independent Director Appointment
31st Jul 20247:00 amRNSHalf-year Report
15th Jul 20247:00 amRNSUpdate on Investment
16th May 20244:54 pmRNSResult of AGM and Dividend Declaration
15th May 20247:00 amRNSDirectorate Change
8th May 20249:19 amRNS1st Quarter Results
25th Apr 20244:09 pmRNSInvestor Presentation
25th Apr 20243:10 pmRNSHolding(s) in Company
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.